allantoin has been researched along with Rheumatic Diseases in 1 studies
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective is to determine whether therapy with TNF inhibitors (TNFis) affects SUA levels in patients with systemic autoimmune rheumatic diseases (SARDs) and whether SUA changes correlate with pro-inflammatory cytokines or with the oxidative stress marker allantoin." | 7.91 | Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors. ( Hasikova, L; Herrmann, M; Hulejova, H; Kalikova, K; Kozlik, P; Mahajan, A; Pavlikova, M; Stiburkova, B; Zavada, J, 2019) |
| " The objective is to determine whether therapy with TNF inhibitors (TNFis) affects SUA levels in patients with systemic autoimmune rheumatic diseases (SARDs) and whether SUA changes correlate with pro-inflammatory cytokines or with the oxidative stress marker allantoin." | 3.91 | Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors. ( Hasikova, L; Herrmann, M; Hulejova, H; Kalikova, K; Kozlik, P; Mahajan, A; Pavlikova, M; Stiburkova, B; Zavada, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasikova, L | 1 |
| Pavlikova, M | 1 |
| Hulejova, H | 1 |
| Kozlik, P | 1 |
| Kalikova, K | 1 |
| Mahajan, A | 1 |
| Herrmann, M | 1 |
| Stiburkova, B | 1 |
| Zavada, J | 1 |
1 other study available for allantoin and Rheumatic Diseases
| Article | Year |
|---|---|
Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allantoin; Antirheumatic Agents; Autoimmune Diseases; Bi | 2019 |